Men whose end-stage cancer was treatment resistant trialled pembrolizumab. A small number of 'super responders' saw their disease 'disappear'. Overall, a quarter of participants showed evidence of the drug working.
It's not new.
Unaffordable if Johnson sells out to the US.
Unaffordable if Johnson sells out to the US.
Two more years of suffering
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Drug could add two more years of life to prostate cancer patientsMen at end-stage cancer trialled pembrolizumab. A small number of 'super responders' saw their disease 'disappear', scientists at The Institute of Cancer Research, London, said. Might have to bookmark this for later. If the heart failure or melanoma don’t get me, I’m guessing the prostate cancer will. Yet, I might just opt out of those last two miserable years Yes but takes too long for hospitals to see them Two years of added agony?
Source: Daily Mail Online - 🏆 135. / 51 Read more »
Prostate cancer breakthrough: New drug could extend life of patients by 'two years' - studyResearchers found some men, who exhausted all other options, were alive and well even after a clinical trial ended.
Source: SkyNews - 🏆 35. / 67 Read more »
Scientist gives away £865k fortune she received for creating life-saving cancer drugA SCIENTIST who dedicated her life’s work to curing cancer has vowed to give away her £865,000 fortune – because she doesn’t “need the money”. Professor Nicola Curtin and her team at Newcastle Univ…
Source: TheSun - 🏆 64. / 61 Read more »
Scientist gives away fortune she earned from patenting life-saving cancer drugBig-hearted researcher donates £865,000 to charity that transforms the lives of disadvantaged people and helps them get work or training.
Source: MetroUK - 🏆 13. / 82 Read more »